Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

68Ga-RM2 PET/CT for Detection of Regional Nodal and Distant Metastases in Patients With Intermediate and High-Risk Prostate Cancer

NCT03113617 is registered in ClinicalTrials.gov with Andrei Iagaru as lead sponsor.

NCT NCT03113617
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03113617 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
68Ga-RM2 PET/CT for Detection of Regional Nodal and Distant Metastases in Patients With Intermediate and High-Risk Prostate Cancer
Lead sponsor
Andrei Iagaru
Phase
Phase 2
Overall status
Completed
Start date
April 10, 2017
Completion date
December 19, 2021
Enrollment
44 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

stage ii prostate adenocarcinoma, stage iii prostate adenocarcinoma, stage iv prostate adenocarcinoma